A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä
Thrombotic microangiopathy associated with bortezomib treatment in a patient with relapsed multiple myeloma
Tekijät: Urpu Salmenniemi, Kari Remes
Julkaisuvuosi: 2012
Journal: Hematology Reports
Artikkelin numero: e13
Numero sarjassa: 2
Vuosikerta: 4
Numero: 2
Aloitussivu: e13
ISSN: 2038-8330
eISSN: 2038-8330
Tiivistelmä
Thrombotic thrombocytopenic purpura (TTP) and hemolytic-uremic syndrome (HUS) describe microvascular occlusive disorders characterized by thrombocytopenia due to increased platelet aggregation and fragmentation hemolysis. We report here what to our knowledge is the second case of TTP/HUS associated with bortezomib treatment.
Thrombotic thrombocytopenic purpura (TTP) and hemolytic-uremic syndrome (HUS) describe microvascular occlusive disorders characterized by thrombocytopenia due to increased platelet aggregation and fragmentation hemolysis. We report here what to our knowledge is the second case of TTP/HUS associated with bortezomib treatment.
Ladattava julkaisu This is an electronic reprint of the original article. |  |
Turun yliopiston Tutkimustietojärjestelmän portaali